J. v. Schönfeld

447 citations
41 papers · 340 indexed · h-index 11
Topics
Pancreatic function and diabetes (9 papers)Liver Disease Diagnosis and Treatment (6 papers)Diabetes Treatment and Management (6 papers)

In The Last Decade

J. v. Schönfeld

35 papers receiving 316 citations

Peers

J. v. Schönfeld
Comparison fields: 5 of 79
  • Surgery 131
  • Gastroenterology 81
  • Physiology 71
  • Pulmonary and Respiratory Medicine 70
  • Molecular Biology 49
Replace Ken Hirabayashi with:
Ken Hirabayashi United States
Bernier Jj France
Martina Lovrić Benčić Croatia
Jacco–Juri de Haan Netherlands
János Lonovics Hungary
L. S. Semb Norway
P. K. Dinda Canada
E. Antonelli Italy
M.A. Devaux France
Vicente P. Dinoso United States
J. v. Schönfeld relative to Ken Hirabayashi United States Ken Hirabayashi's profile →
Citations per field
00.5×
Ken Hirabayashi · 1×
Citations per year

Countries citing papers authored by J. v. Schönfeld

Since Specialization
Citations

This map shows the geographic impact of J. v. Schönfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. v. Schönfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. v. Schönfeld more than expected).

Fields of papers citing papers by J. v. Schönfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. v. Schönfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. v. Schönfeld. The network helps show where J. v. Schönfeld may publish in the future.

Co-authorship network of co-authors of J. v. Schönfeld

This figure shows the co-authorship network connecting the top 25 collaborators of J. v. Schönfeld. A scholar is included among the top collaborators of J. v. Schönfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. v. Schönfeld. J. v. Schönfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 0
5 0
6 8
7 8
8 21
9 23
10 34
11 5
12 21
13 8
14 14
15 2
16 7
17 10
18 3
19 2
20 11

About J. v. Schönfeld

J. v. Schönfeld is a scholar working on Gastroenterology, Hepatology and Endocrinology, Diabetes and Metabolism, having authored 41 papers that have together received 340 indexed citations. Recurring topics across this work include Pancreatic function and diabetes (9 papers), Liver Disease Diagnosis and Treatment (6 papers) and Diabetes Treatment and Management (6 papers). The work is most often cited by research in Gastroenterology (81 citations), Hepatology (26 citations) and Pharmacology (27 citations). J. v. Schönfeld has collaborated with scholars based in Germany, United Kingdom and Israel. Frequent co-authors include D. L. Wingate, Michael Müller, D. F. Evans, H. Goebell, Michael Rünzi, D F Evans, Mark Hector, D L Wingate, N. Breuer and R. B. Zotz. Their work appears in journals such as Gut, Cellular and Molecular Life Sciences and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026